FDA Amendments Act of 2007 (P.L. 110-85).
Examines and summarizes provisions of P.L. 110-85, the Food and Drug Administration Amendments Act (FDAAA) of 2007, which reauthorizes four expiring FDA programs; and expands FDA authority to regulate the safety of prescription drugs and biologics, medical devices, and foods. Provides side-by-side-c...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2008.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Examines and summarizes provisions of P.L. 110-85, the Food and Drug Administration Amendments Act (FDAAA) of 2007, which reauthorizes four expiring FDA programs; and expands FDA authority to regulate the safety of prescription drugs and biologics, medical devices, and foods. Provides side-by-side-comparison of provisions of FDAAA and previous law. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |